Cargando…

Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation

BACKGROUND: Despite quick implementation of reperfusion therapies, a few patients with high-risk, acute, massive, pulmonary embolism (PE) remain highly hemodynamically unstable. Others have absolute contraindication to receive reperfusion therapies. Venoarterial-extracorporeal membrane oxygenation (...

Descripción completa

Detalles Bibliográficos
Autores principales: Corsi, Fillipo, Lebreton, Guillaume, Bréchot, Nicolas, Hekimian, Guillaume, Nieszkowska, Ania, Trouillet, Jean-Louis, Luyt, Charles-Edouard, Leprince, Pascal, Chastre, Jean, Combes, Alain, Schmidt, Matthieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369216/
https://www.ncbi.nlm.nih.gov/pubmed/28347320
http://dx.doi.org/10.1186/s13054-017-1655-8
_version_ 1782518089186803712
author Corsi, Fillipo
Lebreton, Guillaume
Bréchot, Nicolas
Hekimian, Guillaume
Nieszkowska, Ania
Trouillet, Jean-Louis
Luyt, Charles-Edouard
Leprince, Pascal
Chastre, Jean
Combes, Alain
Schmidt, Matthieu
author_facet Corsi, Fillipo
Lebreton, Guillaume
Bréchot, Nicolas
Hekimian, Guillaume
Nieszkowska, Ania
Trouillet, Jean-Louis
Luyt, Charles-Edouard
Leprince, Pascal
Chastre, Jean
Combes, Alain
Schmidt, Matthieu
author_sort Corsi, Fillipo
collection PubMed
description BACKGROUND: Despite quick implementation of reperfusion therapies, a few patients with high-risk, acute, massive, pulmonary embolism (PE) remain highly hemodynamically unstable. Others have absolute contraindication to receive reperfusion therapies. Venoarterial-extracorporeal membrane oxygenation (VA-ECMO) might lower their right ventricular overload, improve hemodynamic status, and restore tissue oxygenation. METHODS: ECMO-related complications and 90-day mortality were analyzed for 17 highly unstable, ECMO-treated, massive PE patients admitted to a tertiary-care center (2006–2015). Hospital- discharge survivors were assessed for long-term health-related quality of life. A systematic review of this topic was also conducted. RESULTS: Seventeen high-risk PE patients [median age 51 (range 18–70) years, Simplified Acute Physiology Score II (SAPS II) 78 (45–95)] were placed on VA-ECMO for 4 (1–12) days. Among 15 (82%) patients with pre-ECMO cardiac arrest, seven (41%) were cannulated during cardiopulmonary resuscitation, and eight (47%) underwent pre-ECMO thrombolysis. Pre-ECMO median blood pressure, pH, and blood lactate were, respectively: 42 (0–106) mmHg, 6.99 (6.54–7.37) and 13 (4–19) mmol/L. Ninety-day survival was 47%. Fifteen (88%) patients suffered in-ICU severe hemorrhages with no impact on survival. Like other ECMO-treated patients, ours reported limitations of all physical domains but preserved mental health 19 (4–69) months post-ICU discharge. CONCLUSIONS: VA-ECMO could be a lifesaving rescue therapy for patients with high-risk, acute, massive PE when thrombolytic therapy fails or the patient is too sick to benefit from surgical thrombectomy. Because heparin-induced clot dissolution and spontaneous fibrinolysis allows ECMO weaning within several days, future studies should investigate whether VA-ECMO should be the sole therapy or completed by additional mechanical clot-removal therapies in this setting. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1655-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5369216
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53692162017-03-30 Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation Corsi, Fillipo Lebreton, Guillaume Bréchot, Nicolas Hekimian, Guillaume Nieszkowska, Ania Trouillet, Jean-Louis Luyt, Charles-Edouard Leprince, Pascal Chastre, Jean Combes, Alain Schmidt, Matthieu Crit Care Research BACKGROUND: Despite quick implementation of reperfusion therapies, a few patients with high-risk, acute, massive, pulmonary embolism (PE) remain highly hemodynamically unstable. Others have absolute contraindication to receive reperfusion therapies. Venoarterial-extracorporeal membrane oxygenation (VA-ECMO) might lower their right ventricular overload, improve hemodynamic status, and restore tissue oxygenation. METHODS: ECMO-related complications and 90-day mortality were analyzed for 17 highly unstable, ECMO-treated, massive PE patients admitted to a tertiary-care center (2006–2015). Hospital- discharge survivors were assessed for long-term health-related quality of life. A systematic review of this topic was also conducted. RESULTS: Seventeen high-risk PE patients [median age 51 (range 18–70) years, Simplified Acute Physiology Score II (SAPS II) 78 (45–95)] were placed on VA-ECMO for 4 (1–12) days. Among 15 (82%) patients with pre-ECMO cardiac arrest, seven (41%) were cannulated during cardiopulmonary resuscitation, and eight (47%) underwent pre-ECMO thrombolysis. Pre-ECMO median blood pressure, pH, and blood lactate were, respectively: 42 (0–106) mmHg, 6.99 (6.54–7.37) and 13 (4–19) mmol/L. Ninety-day survival was 47%. Fifteen (88%) patients suffered in-ICU severe hemorrhages with no impact on survival. Like other ECMO-treated patients, ours reported limitations of all physical domains but preserved mental health 19 (4–69) months post-ICU discharge. CONCLUSIONS: VA-ECMO could be a lifesaving rescue therapy for patients with high-risk, acute, massive PE when thrombolytic therapy fails or the patient is too sick to benefit from surgical thrombectomy. Because heparin-induced clot dissolution and spontaneous fibrinolysis allows ECMO weaning within several days, future studies should investigate whether VA-ECMO should be the sole therapy or completed by additional mechanical clot-removal therapies in this setting. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1655-8) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-28 /pmc/articles/PMC5369216/ /pubmed/28347320 http://dx.doi.org/10.1186/s13054-017-1655-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Corsi, Fillipo
Lebreton, Guillaume
Bréchot, Nicolas
Hekimian, Guillaume
Nieszkowska, Ania
Trouillet, Jean-Louis
Luyt, Charles-Edouard
Leprince, Pascal
Chastre, Jean
Combes, Alain
Schmidt, Matthieu
Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation
title Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation
title_full Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation
title_fullStr Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation
title_full_unstemmed Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation
title_short Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation
title_sort life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369216/
https://www.ncbi.nlm.nih.gov/pubmed/28347320
http://dx.doi.org/10.1186/s13054-017-1655-8
work_keys_str_mv AT corsifillipo lifethreateningmassivepulmonaryembolismrescuedbyvenoarterialextracorporealmembraneoxygenation
AT lebretonguillaume lifethreateningmassivepulmonaryembolismrescuedbyvenoarterialextracorporealmembraneoxygenation
AT brechotnicolas lifethreateningmassivepulmonaryembolismrescuedbyvenoarterialextracorporealmembraneoxygenation
AT hekimianguillaume lifethreateningmassivepulmonaryembolismrescuedbyvenoarterialextracorporealmembraneoxygenation
AT nieszkowskaania lifethreateningmassivepulmonaryembolismrescuedbyvenoarterialextracorporealmembraneoxygenation
AT trouilletjeanlouis lifethreateningmassivepulmonaryembolismrescuedbyvenoarterialextracorporealmembraneoxygenation
AT luytcharlesedouard lifethreateningmassivepulmonaryembolismrescuedbyvenoarterialextracorporealmembraneoxygenation
AT leprincepascal lifethreateningmassivepulmonaryembolismrescuedbyvenoarterialextracorporealmembraneoxygenation
AT chastrejean lifethreateningmassivepulmonaryembolismrescuedbyvenoarterialextracorporealmembraneoxygenation
AT combesalain lifethreateningmassivepulmonaryembolismrescuedbyvenoarterialextracorporealmembraneoxygenation
AT schmidtmatthieu lifethreateningmassivepulmonaryembolismrescuedbyvenoarterialextracorporealmembraneoxygenation